Design Therapeutics, Inc. has been removed from NASDAQ Biotechnology Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 USD | +0.45% | -3.84% | +70.19% |
May. 08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.19% | 255M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.01% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- Design Therapeutics, Inc.(NasdaqGS: DSGN) dropped from NASDAQ Biotechnology Index